Guillain-Barrého syndrom u pacienta s COVID-19

Czech version

Authors: B. Adamová ^1,2; M. Škorňa ¹; K. Jurisová ¹; P. Krkoška ^1,2
Authors‘ workplace: Neurologická klinika FN Brno ¹; LF MU Brno ²
Published in: Cesk Slov Neurol N 2021; 84(6): 589-590
Category: Letters to Editor
doi: https://doi.org/10.48095/cccsnn2021589

Sources

1. van den Berg B, Walgaard C, Drenthen J et al. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 2014; 10(8): 469–482. doi: 10.1038/nrneurol.2014.121.

2. Rajabally YA, Durand MC, Mitchell J et al. Electrophysiological diagnosis of Guillain-Barré syndrome subtype: could a single study suffice? J Neurol Neurosurg Psychiatry 2015; 86(1): 115–119. doi: 10.1136/jnnp-2014-307815.

3. Zhao H, Shen D, Zhou H et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 2020; 19(5): 383–384. doi: 10.1016/S1474-4422(20)30109-5.

4. Foresti C, Servalli MC, Frigeni B et al. COVID-19 provoking Guillain-Barré syndrome: The Bergamo case series. Eur J Neurol 2021; 28(10): e84–e85. doi: 10.1111/ene.14549.

5. Filosto M, Piccinelli SC, Gazzina S et al. Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions. J Neurol Neurosurg Psychiatry 2021; 92(7): 751–756. doi: 10.1136/jnnp-2020-324837.

6. Keddie S, Pakpoor J, Mousele C et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. Brain 2021; 144(2): 682–693. doi: 10.1093/brain/awaa433.

7. Vogrig A, Moritz CP, Camdessanché JP et al. Unclear association between COVID-19 and Guillain-Barré syndrome. Brain 2021; 144(5): e45. doi: 10.1093/brain/awab068.

8. Palaiodimou L, Stefanou MI, Katsanos AH et al. Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: a systematic review and meta-analysis. Eur J Neurol 2021; 28(10): 3517–3529. doi: 10.1111/ene.14860.

9. Gigli GL, Vogrig A, Nilo A et al. HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome. Neurol Sci 2020; 41(12): 3391–3394. doi: 10.1007/s10072-020-04787-7.

10. Finsterer J, Scorza FA. Guillain-Barre syndrome in 220 patients with COVID-19. Egypt J Neurol Psychiatr Neurosurg 2021; 57(1): 55. doi: 10.1186/s41983-021-00310-7.

11. Hasan I, Saif-Ur-Rahman KM, Hayat S et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection: a systematic review and individual participant data meta-analysis. J Peripher Nerv Syst 2020; 25(4): 335–343. doi: 10.1111/jns.12419.